2022 Q4 Form 20-F Financial Statement

#000095017023013293 Filed on April 18, 2023

View on sec.gov

Income Statement

Concept 2022 Q4 2022 2021 Q4
Revenue $12.74M $983.2M
YoY Change 2392.76%
Cost Of Revenue $89.29M $753.0M
YoY Change 1629.82%
Gross Profit -$76.55M $230.2M
YoY Change -5727.76%
Gross Profit Margin -600.9% 23.41%
Selling, General & Admin $21.11M $77.63M
YoY Change 165.48%
% of Gross Profit 33.73%
Research & Development $39.21M $131.9M
YoY Change -9.35%
% of Gross Profit 57.29%
Depreciation & Amortization $564.0K
YoY Change -78.39%
% of Gross Profit 0.25%
Operating Expenses $60.32M $209.5M
YoY Change 19.91%
Operating Profit -$136.9M $20.68M
YoY Change -111.57%
Interest Expense $1.389M $6.413M
YoY Change 114.81%
% of Operating Profit 31.0%
Other Income/Expense, Net $2.691M $4.022M
YoY Change 369.83%
Pretax Income -$132.8M $31.12M
YoY Change -117.79%
Income Tax $0.00 $0.00
% Of Pretax Income 0.0%
Net Earnings -$132.8M $31.12M
YoY Change -117.79%
Net Earnings / Revenue -1042.34% 3.17%
Basic Earnings Per Share $0.29
Diluted Earnings Per Share -$1.19 $0.28
COMMON SHARES
Basic Shares Outstanding 106.5M
Diluted Shares Outstanding 106.6M

Balance Sheet

Concept 2022 Q4 2022 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $87.81M $87.81M
YoY Change -66.96%
Cash & Equivalents $87.81M $87.81M $233.9M
Short-Term Investments $0.00 $0.00
Other Short-Term Assets $98.64M $98.64M $41.46M
YoY Change 137.91% -74.09%
Inventory $102.2M $102.2M $213.9M
Prepaid Expenses $71.31M $372.4M
Receivables
Other Receivables
Total Short-Term Assets $288.7M $288.7M $893.4M
YoY Change -67.69% -67.69%
LONG-TERM ASSETS
Property, Plant & Equipment $29.87M $29.87M $7.249M
YoY Change 312.12% 82.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $78.59M $78.59M $16.40M
YoY Change 379.08% 379.08%
TOTAL ASSETS
Total Short-Term Assets $288.7M $288.7M $893.4M
Total Long-Term Assets $78.59M $78.59M $16.40M
Total Assets $367.2M $367.2M $909.8M
YoY Change -59.64% -59.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $15.29M $15.29M $2.838M
YoY Change 438.93% 438.93%
Accrued Expenses $4.199M $4.199M
YoY Change -19.63%
Deferred Revenue $124.5M $917.4M
YoY Change -86.43%
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $280.0K $280.0K $0.00
YoY Change
Total Short-Term Liabilities $183.6M $183.6M $932.4M
YoY Change -80.3% -80.3%
LONG-TERM LIABILITIES
Long-Term Debt $16.67M $16.67M
YoY Change
Other Long-Term Liabilities $2.514M $2.514M
YoY Change 18.46%
Total Long-Term Liabilities $19.19M $19.19M
YoY Change 804.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $183.6M $183.6M $932.4M
Total Long-Term Liabilities $19.19M $19.19M
Total Liabilities $202.8M $202.8M $934.5M
YoY Change -78.3% -78.3%
SHAREHOLDERS EQUITY
Retained Earnings -$28.60M -$223.7M
YoY Change -87.21%
Common Stock 354.8M cnies $66.97K
YoY Change 529694.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $164.4M $164.4M -$24.66M
YoY Change
Total Liabilities & Shareholders Equity $367.2M $367.2M $909.8M
YoY Change -59.64% -59.64%

Cashflow Statement

Concept 2022 Q4 2022 2021 Q4
OPERATING ACTIVITIES
Net Income -$132.8M $31.12M
YoY Change -117.79%
Depreciation, Depletion And Amortization $564.0K
YoY Change -78.39%
Cash From Operating Activities -$39.48M
YoY Change -155.03%
INVESTING ACTIVITIES
Capital Expenditures $2.517M
YoY Change -71.04%
Acquisitions
YoY Change
Other Investing Activities $33.64M
YoY Change -222.98%
Cash From Investing Activities -$4.765M
YoY Change -86.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $20.10K
YoY Change
Cash From Financing Activities 23.12M
YoY Change -85.98%
NET CHANGE
Cash From Operating Activities -39.48M
Cash From Investing Activities -4.765M
Cash From Financing Activities 23.12M
Net Change In Cash -20.96M
YoY Change -110.45%
FREE CASH FLOW
Cash From Operating Activities -$39.48M
Capital Expenditures $2.517M
Free Cash Flow -$41.99M
YoY Change -166.61%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87811272
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12608229
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
0
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
48112
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
6908
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0001872302
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q2 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.00010
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022 dei Document Type
DocumentType
20-F
CY2022 dei Document Registration Statement
DocumentRegistrationStatement
false
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-12-31
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Document Shell Company Report
DocumentShellCompanyReport
false
CY2022 dei Entity File Number
EntityFileNumber
001-41426
CY2022 dei Entity Registrant Name
EntityRegistrantName
Nano Labs Ltd
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
30th Floor, Dikaiyinzuo
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
No. 29, East Jiefang Road
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Hangzhou, Zhejiang
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
310000
CY2022 dei Entity Address Country
EntityAddressCountry
CN
CY2022 dei Security12b Title
Security12bTitle
American depositary shares, each representing two Class A ordinary shares, par value US$0.0001 per share Class A ordinary shares, par value US$0.0001
CY2022 dei Trading Symbol
TradingSymbol
NA
CY2022 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2022 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2022 dei Document Accounting Standard
DocumentAccountingStandard
U.S. GAAP
CY2022 dei Entity Shell Company
EntityShellCompany
true
CY2022 dei Auditor Firm
AuditorFirmId
206
CY2022 dei Auditor Name
AuditorName
MaloneBailey, LLP
CY2022 dei Auditor Location
AuditorLocation
Houston, Texas
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233853654
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
31888500
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2022Q4 us-gaap Short Term Investments
ShortTermInvestments
0
CY2021Q4 us-gaap Inventory Net
InventoryNet
213870251
CY2022Q4 us-gaap Inventory Net
InventoryNet
102201746
CY2022Q4 us-gaap Inventory Net
InventoryNet
14674460
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
372355129
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
71314254
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
10239533
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
41460490
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
27275215
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3916264
CY2021Q4 us-gaap Assets Current
AssetsCurrent
893428024
CY2022Q4 us-gaap Assets Current
AssetsCurrent
288650599
CY2022Q4 us-gaap Assets Current
AssetsCurrent
41445394
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7249044
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21426955
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3076552
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48717132
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
6994964
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
9155665
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
8447978
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1212988
CY2021Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
16404709
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
78592065
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
11284504
CY2021Q4 us-gaap Assets
Assets
909832733
CY2022Q4 us-gaap Assets
Assets
367242664
CY2022Q4 us-gaap Assets
Assets
52729898
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
280000
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
40203
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2837638
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
15292843
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2195796
CY2021Q4 ck0001872302 Advanced From Customer Current
AdvancedFromCustomerCurrent
917391899
CY2022Q4 ck0001872302 Advanced From Customer Current
AdvancedFromCustomerCurrent
124469097
CY2022Q4 ck0001872302 Advanced From Customer Current
AdvancedFromCustomerCurrent
17871679
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5224757
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
4199361
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
602958
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6917757
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39399532
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
5657111
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
932372051
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
183640833
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
26367747
CY2021Q4 ck0001872302 Long Term Debts
LongTermDebts
0
CY2022Q4 ck0001872302 Long Term Debts
LongTermDebts
16673316
CY2022Q4 ck0001872302 Long Term Debts
LongTermDebts
2394009
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2122357
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2514115
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
360985
CY2021Q4 us-gaap Liabilities
Liabilities
934494408
CY2022Q4 us-gaap Liabilities
Liabilities
202828264
CY2022Q4 us-gaap Liabilities
Liabilities
29122741
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103790000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103790000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
66970
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
201418380
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
354803564
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
50943854
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-223679698
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-199207921
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-28602923
CY2021Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
0
CY2022Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
6647109
CY2022Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
954414
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-2467327
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
2099329
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
301429
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-24661675
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
164414400
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
23607157
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
909832733
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
367242664
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
52729898
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2126676
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39440897
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983168898
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
141166599
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
1270544
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
43530708
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
753004179
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
108118798
CY2020 us-gaap Gross Profit
GrossProfit
856132
CY2021 us-gaap Gross Profit
GrossProfit
-4089811
CY2022 us-gaap Gross Profit
GrossProfit
230164719
CY2022 us-gaap Gross Profit
GrossProfit
33047801
CY2020 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
108567
CY2021 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
5119072
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
24431649
CY2022 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
3507976
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3187033
CY2021 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
24121823
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
53197248
CY2022 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7638235
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
34476484
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
145455181
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
131851602
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
18931683
CY2020 us-gaap Operating Expenses
OperatingExpenses
37772084
CY2021 us-gaap Operating Expenses
OperatingExpenses
174696076
CY2022 us-gaap Operating Expenses
OperatingExpenses
209480499
CY2022 us-gaap Operating Expenses
OperatingExpenses
30077894
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-36915952
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-178785887
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
20684220
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2969907
CY2020 ck0001872302 Finance Income Expense
FinanceIncomeExpense
-3747
CY2021 ck0001872302 Finance Income Expense
FinanceIncomeExpense
-509764
CY2022 ck0001872302 Finance Income Expense
FinanceIncomeExpense
4407504
CY2022 ck0001872302 Finance Income Expense
FinanceIncomeExpense
632844
CY2020 us-gaap Interest Income Other
InterestIncomeOther
17915
CY2021 us-gaap Interest Income Other
InterestIncomeOther
3495208
CY2022 us-gaap Interest Income Other
InterestIncomeOther
2005580
CY2022 us-gaap Interest Income Other
InterestIncomeOther
287968
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-800000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
855959
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
4021582
CY2022 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
577432
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-785832
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
3841403
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10434666
CY2022 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1498244
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-37701784
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-174944484
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
31118886
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4468151
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2293
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37704077
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-174944484
CY2022 us-gaap Net Income Loss
NetIncomeLoss
31118886
CY2022 us-gaap Net Income Loss
NetIncomeLoss
4468151
CY2020 us-gaap Profit Loss
ProfitLoss
-37704077
CY2021 us-gaap Profit Loss
ProfitLoss
-174944484
CY2022 us-gaap Profit Loss
ProfitLoss
31118886
CY2022 us-gaap Profit Loss
ProfitLoss
4468151
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
0
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
2467327
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-4566656
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
-655695
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-37704077
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-177411811
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
35685542
CY2022 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
5123846
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.95
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.04
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.04
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79249000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89877975
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106488996
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106488996
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79249000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89877975
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106615210
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106615210
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-11031137
CY2020 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
214882
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37704077
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-48520332
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
201199989
CY2021 ck0001872302 Cash Contribution From Shareholders
CashContributionFromShareholders
51135
CY2021 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
19344
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-174944484
CY2021 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2467327
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-24661675
CY2022 ck0001872302 Stock Issued During Period Value Share Issuance Initial Public Offering Net Of Issuance Cost
StockIssuedDuringPeriodValueShareIssuanceInitialPublicOfferingNetOfIssuanceCost
111939400
CY2022 ck0001872302 Stock Issued During Period Value Share Issuance Following Initial Public Offering Net Of Issuance Cost
StockIssuedDuringPeriodValueShareIssuanceFollowingInitialPublicOfferingNetOfIssuanceCost
32103786
CY2022 us-gaap Net Income Loss
NetIncomeLoss
31118886
CY2022 us-gaap Stock Issued During Period Value Share Based Compensation Gross
StockIssuedDuringPeriodValueShareBasedCompensationGross
9347347
CY2022 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
4566656
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
164414400
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
23607157
CY2020 us-gaap Profit Loss
ProfitLoss
-37704077
CY2021 us-gaap Profit Loss
ProfitLoss
-174944484
CY2022 us-gaap Profit Loss
ProfitLoss
31118886
CY2022 us-gaap Profit Loss
ProfitLoss
4468151
CY2020 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
269315
CY2021 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
2920433
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
5505422
CY2022 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
790486
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
353557
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2609699
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3928131
CY2022 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
564014
CY2020 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
12088
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0
CY2022 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
0
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
214882
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
19344
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
9347347
CY2022 us-gaap Share Based Compensation
ShareBasedCompensation
1342123
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
26753768
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
184073191
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
26429830
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1165716
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1165716
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0
CY2020 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
7238293
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
233385726
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
71446484
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10258519
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
2126527
CY2021 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
364369453
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-304300103
CY2022 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-43692401
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
2575074
CY2021 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
38564595
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-51740635
CY2022 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-7429089
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
390152
CY2021 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1937951
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
10591202
CY2022 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1520719
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-4716981
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
0
CY2020 ck0001872302 Increase Decrease In Advance From Customers
IncreaseDecreaseInAdvanceFromCustomers
45033520
CY2021 ck0001872302 Increase Decrease In Advance From Customers
IncreaseDecreaseInAdvanceFromCustomers
851987235
CY2022 ck0001872302 Increase Decrease In Advance From Customers
IncreaseDecreaseInAdvanceFromCustomers
-794302470
CY2022 ck0001872302 Increase Decrease In Advance From Customers
IncreaseDecreaseInAdvanceFromCustomers
-114048541
CY2020 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
168553
CY2021 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-175721
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-19683959
CY2022 us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
-2826287
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-302256
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-4687184
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5330448
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-765363
CY2020 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1654065
CY2021 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
5194954
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
15217655
CY2022 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
2185001
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3027899
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
71732868
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-274940789
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-39476896
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
936776
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8692683
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
17531162
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2517181
CY2020 ck0001872302 Refund Of Prepayment For Property And Equipment
RefundOfPrepaymentForPropertyAndEquipment
0
CY2021 ck0001872302 Refund Of Prepayment For Property And Equipment
RefundOfPrepaymentForPropertyAndEquipment
550000
CY2022 ck0001872302 Refund Of Prepayment For Property And Equipment
RefundOfPrepaymentForPropertyAndEquipment
0
CY2022 ck0001872302 Refund Of Prepayment For Property And Equipment
RefundOfPrepaymentForPropertyAndEquipment
0
CY2020 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2021 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
32293440
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2022 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
0
CY2020 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2021 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
33640500
CY2022 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
4830213
CY2020 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2021 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
49292208
CY2022 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
7077536
CY2020 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
2270000
CY2021 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
100000
CY2022 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0
CY2022 us-gaap Payments To Fund Longterm Loans To Related Parties
PaymentsToFundLongtermLoansToRelatedParties
0
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1560000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
4490000
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
CY2022 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
0
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1646776
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-36046123
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-33182870
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4764504
CY2020 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
30255000
CY2021 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2022 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
0
CY2020 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-890000
CY2021 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
-31355000
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0
CY2022 us-gaap Proceeds From Repayments Of Related Party Debt
ProceedsFromRepaymentsOfRelatedPartyDebt
0
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
201199989
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
144043186
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20682191
CY2020 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
CY2021 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
51135
CY2022 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
CY2022 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0
CY2020 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2021 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
0
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
17093316
CY2022 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
2454314
CY2020 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2021 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
140000
CY2022 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
20102
CY2020 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
CY2021 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5000000
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
CY2022 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
29365000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
164896124
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
160996502
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
23116403
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
0
CY2021 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-2062387
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1132887
CY2022 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
162663
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
24690325
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
198520482
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-145994270
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-20962334
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10642847
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35333172
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233853654
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33577471
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
35333172
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
233853654
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
87859384
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12615137
CY2020 us-gaap Interest Paid Net
InterestPaidNet
0
CY2021 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
180619
CY2022 us-gaap Interest Paid Net
InterestPaidNet
25934
CY2020 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2336
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
276186
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
89169
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
12803
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
0
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
4557092
CY2022 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
654322
CY2020 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2126676
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-left:24.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Use of estimates</span></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of the Company’s consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Significant accounting estimates reflected in the Company's consolidated financial statements including, but not limited to, inventory write-down, valuation allowance for deferred tax assets and share-based compensation.</span></p>
CY2022 ck0001872302 Foreign Currency Exchange Rate Translation
ForeignCurrencyExchangeRateTranslation
US$1.00=RMB6.9646
CY2022 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="margin-left:24.5pt;text-indent:0.0pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;font-style:italic;min-width:fit-content;">Concentration of credit risk</span></p><p style="text-indent:24.5pt;font-size:10.0pt;margin-top:12.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:11.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents. The Company places its cash and cash equivalents with financial institutions with high credit ratings and quality.</span></p>
CY2021 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
39440897
CY2022 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
983168898
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
917391899
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
233853654
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
87811272
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
48112
CY2020 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2021 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2022Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
124469097
CY2020 ck0001872302 Contract Liabilities As Revenue
ContractLiabilitiesAsRevenue
1165716
CY2021 ck0001872302 Contract Liabilities As Revenue
ContractLiabilitiesAsRevenue
4241270
CY2022 ck0001872302 Contract Liabilities As Revenue
ContractLiabilitiesAsRevenue
804875532
CY2020 us-gaap Inventory Write Down
InventoryWriteDown
0
CY2021 us-gaap Inventory Write Down
InventoryWriteDown
26753768
CY2022 us-gaap Inventory Write Down
InventoryWriteDown
184073191
CY2020 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
108567
CY2021 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
992996
CY2022 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
10901200
CY2020 ck0001872302 Shipping And Handling Costs
ShippingAndHandlingCosts
0
CY2021 ck0001872302 Shipping And Handling Costs
ShippingAndHandlingCosts
371769
CY2022 ck0001872302 Shipping And Handling Costs
ShippingAndHandlingCosts
4233084
CY2022Q4 us-gaap Inventory Adjustments
InventoryAdjustments
208213546
CY2021Q4 us-gaap Inventory Net
InventoryNet
213870251
CY2022Q4 us-gaap Inventory Net
InventoryNet
102201746
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2734442
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6087694
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
7249044
CY2021Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
7108562
CY2022Q4 us-gaap Deferred Offering Costs
DeferredOfferingCosts
0
CY2021Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
919630
CY2022Q4 us-gaap Deposits Assets Current
DepositsAssetsCurrent
3434080
CY2021Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
354806
CY2022Q4 us-gaap Other Assets Miscellaneous Current
OtherAssetsMiscellaneousCurrent
109548
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
41460490
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
27275215
CY2021Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
61673722
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
69914306
CY2021Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
115246904
CY2022Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
158693203
CY2021Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
63703393
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
81807783
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
26753768
CY2021Q4 ck0001872302 Prepayments Inventories And Processing Fee
PrepaymentsInventoriesAndProcessingFee
369183083
CY2022Q4 ck0001872302 Prepayments Inventories And Processing Fee
PrepaymentsInventoriesAndProcessingFee
64813532
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
3172046
CY2022Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
6500722
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
372355129
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
71314254
CY2021Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
33077492
CY2022Q4 us-gaap Value Added Tax Receivable Current
ValueAddedTaxReceivableCurrent
23731587
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21426955
CY2020 us-gaap Depreciation
Depreciation
187277
CY2021 us-gaap Depreciation
Depreciation
2510398
CY2022 us-gaap Depreciation
Depreciation
3353055
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-334865
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-909941
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48717132
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
166280
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
99301
CY2022 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
575076
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
0
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48717132
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
985844
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
985844
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
985844
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
985844
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
985844
CY2022Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
43787912
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
48717132
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
166666
CY2022 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
9329484
CY2022Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
5887864
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.2635
CY2022 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
1.7126
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
389799
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
3277780
CY2022 us-gaap Operating Lease Cost
OperatingLeaseCost
11385312
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
48000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
1867850
CY2022 us-gaap Short Term Lease Cost
ShortTermLeaseCost
295564
CY2020 us-gaap Lease Cost
LeaseCost
437799
CY2021 us-gaap Lease Cost
LeaseCost
5145630
CY2022 us-gaap Lease Cost
LeaseCost
11680876
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
335162
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
5068864
CY2022 us-gaap Operating Lease Payments
OperatingLeasePayments
5822406
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y10M9D
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y7M24D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0624
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0624
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
4239198
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
2542911
CY2022Q4 ck0001872302 Lesseeoperatingleaseliabilitypaymentsdueafteryeartwo
Lesseeoperatingleaseliabilitypaymentsdueafteryeartwo
0
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
6782109
CY2022Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
68633
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
6713476
CY2021 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0022
CY2022 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.0091
CY2020 ck0001872302 Effective Income Tax Rate Reconciliation Deductible And Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationDeductibleAndNondeductibleExpenseResearchAndDevelopment
0.2150
CY2021 ck0001872302 Effective Income Tax Rate Reconciliation Deductible And Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationDeductibleAndNondeductibleExpenseResearchAndDevelopment
0.1518
CY2021Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
6591805
CY2022Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
8536985
CY2021Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
0
CY2022Q4 us-gaap Deposit Liability Current
DepositLiabilityCurrent
10000000
CY2021Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
321443
CY2022Q4 us-gaap Accrual For Taxes Other Than Income Taxes Current
AccrualForTaxesOtherThanIncomeTaxesCurrent
13609170
CY2021Q4 ck0001872302 Others Liabilities Current
OthersLiabilitiesCurrent
4509
CY2022Q4 ck0001872302 Others Liabilities Current
OthersLiabilitiesCurrent
7253377
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
6917757
CY2022Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
39399532
CY2022 ck0001872302 Effective Income Tax Rate Reconciliation Deductible And Nondeductible Expense Research And Development
EffectiveIncomeTaxRateReconciliationDeductibleAndNondeductibleExpenseResearchAndDevelopment
-0.6443
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.0002
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.1314
CY2022 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
-0.5677
CY2020 ck0001872302 Effective Income Tax Rate Reconciliation Recovery From Deferred Income Tax Assets
EffectiveIncomeTaxRateReconciliationRecoveryFromDeferredIncomeTaxAssets
0.0000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
280000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
420000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
560000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
700000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
840000
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
14153316
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
16953316
CY2021 us-gaap Stockholders Equity Note Stock Split
StockholdersEquityNoteStockSplit
On January 8, 2021, Nano Labs Ltd was incorporated in the Cayman Islands. In April 2021, the Board of the Company approved a one-for-10,000 shares subdivision, following which the authorized share capital of US$50,000 was divided into 500,000,000 ordinary shares with a par value of US$0.0001 each.In January and March 2021, the Company issued ordinary shares, which equivalent to a total of 79,249,000 ordinary shares after the reorganization, to six original shareholders of Zhejiang Haowei with cash proceeds of US$7,925. In April and May 2021, the Company entered into agreements with fourteen new shareholders to issue a total of 20,751,000 ordinary shares for total cash proceeds of RMB 81,000,000 (approximately US$12,600,000). In July 2021, the total of 20,751,000 ordinary shares were issued and the proceeds had been fully collected as of December 31, 2021. In August 2021, the Company entered into agreements with six new shareholders to issue a total of 3,790,000 ordinary shares for total consideration of US$18,950,000 (approximately RMB122,300,000). In November 2021, the total of 3,790,000 shares were issued and the proceeds had been fully collected as of December 31, 2021. Immediately prior to the completion of the initial public offering (“IPO”) on July 12, 2022, the Company adopted a dual-class share structure, consisting of Class A ordinary shares and Class B ordinary shares, with par value of US$0.0001 per share. 57,178,154 ordinary shares, beneficially owned by Mr. Jianping Kong and Mr. Qifeng Sun, the founders of the Company, were re-designated into Class B ordinary shares on a one-for-one basis, and the remaining 46,611,846 ordinary shares were re-designated into Class A ordinary shares on a one-for-one basis.Each Class A ordinary share is entitled to one vote per share and each Class B ordinary share is entitled to 15 votes per share. Each Class B ordinary share is convertible at any time into one Class A ordinary share, while Class A ordinary shares are not convertible into Class B ordinary shares.On July 14, 2022, the Company completed the IPO with new issuance of totaling 1,770,000 ADSs representing 3,540,000 Class A ordinary shares at a price of US$11.50 per ADS or US$5.75 per ordinary share for gross proceeds of approximately US$20.4 million. The Company received all the net proceeds of approximately US$16.6 million after deducting underwriting discounts and commissions and other offering expenses by July 14, 2022. On September 30, 2022, the Company completed the supplemental offering with new issuance of totaling 2,083,334 ADSs representing 4,166,668 Class A ordinary shares at price of US$2.40 per ADS or US$1.20 per share for gross proceeds of approximately US$5.0 million. The Company received all the net proceeds of approximately US$4.5 million after deducting underwriting discounts and commissions and other offering expenses by October 5, 2022. As of December 31, 2021 and 2022, there were 103,790,000 and 111,496,668 ordinary shares issued and outstanding, respectively.
CY2021Q1 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
50000
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
79249000
CY2021Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
7925
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20751000
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
81000000
CY2021Q2 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
12600000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
20751000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3790000
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
18950000
CY2021Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
122300000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3790000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
103790000
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
103790000
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111496668
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
111496668
CY2021 ck0001872302 Effective Income Tax Rate Reconciliation Recovery From Deferred Income Tax Assets
EffectiveIncomeTaxRateReconciliationRecoveryFromDeferredIncomeTaxAssets
0.0000
CY2022 ck0001872302 Effective Income Tax Rate Reconciliation Recovery From Deferred Income Tax Assets
EffectiveIncomeTaxRateReconciliationRecoveryFromDeferredIncomeTaxAssets
-0.9739
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4616
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500000
CY2022Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.0002
CY2022Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P10Y
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.333
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P1Y
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.333
CY2023 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P2Y
CY2024 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Award Vesting Rights Percentage
SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
0.333
CY2024 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Requisite Service Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1
P3Y
CY2022Q1 ck0001872302 Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Sport Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsSportPrice
4.80
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.3701
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0151
CY2022Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0000
CY2022Q1 ck0001872302 Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsForfeitureRate
0.0000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
500000
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.001
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P10Y
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.47
CY2022 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0
CY2022 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0
CY2022 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
500000
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.001
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P9Y
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
30.47
CY2022 us-gaap Statutory Accounting Practices Statutory Capital And Surplus Variations
StatutoryAccountingPracticesStatutoryCapitalAndSurplusVariations
Appropriation to the statutory general reserve should be at least 10% of the after tax net income determined in accordance with the legal requirements in the PRC until the reserve is equal to 50% of the entities’ registered capital. The Company is not required to make appropriation to other reserve funds and the Company does not have any intentions to make appropriations to any other reserve funds.
CY2022Q4 us-gaap Statutory Accounting Practices Retained Earnings Not Available For Dividends
StatutoryAccountingPracticesRetainedEarningsNotAvailableForDividends
6647109
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37704077
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-174944484
CY2022 us-gaap Net Income Loss
NetIncomeLoss
31118886
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
79249000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
89877975
CY2022 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
106488996
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.48
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.95
CY2022 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-37704077
CY2021 us-gaap Net Income Loss
NetIncomeLoss
-174944484
CY2022 us-gaap Net Income Loss
NetIncomeLoss
31118886
CY2020 ck0001872302 Weighted Average Number Diluted Shares Outstanding Before Adjustment
WeightedAverageNumberDilutedSharesOutstandingBeforeAdjustment
79249000
CY2021 ck0001872302 Weighted Average Number Diluted Shares Outstanding Before Adjustment
WeightedAverageNumberDilutedSharesOutstandingBeforeAdjustment
89877975
CY2022 ck0001872302 Weighted Average Number Diluted Shares Outstanding Before Adjustment
WeightedAverageNumberDilutedSharesOutstandingBeforeAdjustment
106488996
CY2020 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2021 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2022 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
126214
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
79249000
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
89877975
CY2022 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
106615210
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.48
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.95
CY2022 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2020 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2500
CY2021 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2500
CY2022 us-gaap Effective Income Tax Rate Reconciliation Repatriation Of Foreign Earnings
EffectiveIncomeTaxRateReconciliationRepatriationOfForeignEarnings
0.2500
CY2020 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
-0.0038
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.0000
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.0047
CY2022 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.2142
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0002
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2022 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2293
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2022 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
0
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2022 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2293
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
53517161
CY2022Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
63038127
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
3960446
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
29335373
CY2021Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
5004834
CY2022Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
47198866
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
62482441
CY2022Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
80901620
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
62482441
CY2022Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
80901620
CY2021Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2022Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0
CY2020 ck0001872302 Deferred Tax Assets Provision For Valuation Allowance
DeferredTaxAssetsProvisionForValuationAllowance
16396474
CY2021 ck0001872302 Deferred Tax Assets Provision For Valuation Allowance
DeferredTaxAssetsProvisionForValuationAllowance
42631572
CY2022 ck0001872302 Deferred Tax Assets Provision For Valuation Allowance
DeferredTaxAssetsProvisionForValuationAllowance
24519326
CY2022 ck0001872302 Reversal Of Valuation Allowance
ReversalOfValuationAllowance
6100147
CY2022Q4 ck0001872302 Other Parties Demand Of Return Payment
OtherPartiesDemandOfReturnPayment
44941000

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000950170-23-013293-index-headers.html Edgar Link pending
0000950170-23-013293-index.html Edgar Link pending
0000950170-23-013293.txt Edgar Link pending
0000950170-23-013293-xbrl.zip Edgar Link pending
ck0001872302-20221231.htm Edgar Link pending
ck0001872302-20221231.xsd Edgar Link pending
ck0001872302-ex11_2.htm Edgar Link pending
ck0001872302-ex12_1.htm Edgar Link pending
ck0001872302-ex12_2.htm Edgar Link pending
ck0001872302-ex13_1.htm Edgar Link pending
ck0001872302-ex13_2.htm Edgar Link pending
ck0001872302-20221231_cal.xml Edgar Link unprocessable
ck0001872302-20221231_pre.xml Edgar Link unprocessable
ck0001872302-20221231_def.xml Edgar Link unprocessable
ck0001872302-20221231_lab.xml Edgar Link unprocessable
ck0001872302-20221231_htm.xml Edgar Link completed
ck0001872302-ex15_1.htm Edgar Link pending
ck0001872302-ex2_4.htm Edgar Link pending
ck0001872302-ex8_1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
img246355806_0.jpg Edgar Link pending
img51318943_0.jpg Edgar Link pending
img51318943_1.jpg Edgar Link pending
img51318943_2.jpg Edgar Link pending
img51318943_3.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending